As regards immunohistochemistry in this diagnostic setting, WT1 immunoreactivity in a high-grade serous carcinoma, particularly if diffuse, favors tubo-ovarian origin (90%–95% of tubo-ovarian high-grade serous adenocarcinomas are WT1 positive) (Fig. 8). This evidence concerns the gene WT1 and serous adenocarcinoma.